AOA calls for antitrust protection before Supreme Court case
With a Supreme Court case looming that could affect how state boards regulate professions—including optometry—the AOA is taking action. The AOA contends that state optometry and other licensing boards should not be subjected to federal antitrust scrutiny and oversight.
On Oct. 14, the United States Supreme Court is scheduled to hear North Carolina State Board of Dental Examiners vs. Federal Trade Commission, a case with implications for regulations on professions and on nonlicensed professionals.
An earlier ruling by the Fourth Circuit Court of Appeals determined that North Carolina's state dental board was a "private actor," meaning it would not qualify for exemption from federal antitrust laws unless it followed certain provisions, such as being actively supervised by the state.
Depending on how the high court rules on the earlier decision by the appeals court, the case could affect all state licensing boards, not just dentistry.
AOA calls for antitrust protection
The AOA opposes the Fourth Circuit Court's decision on the basis that it would subject state optometry boards and the ODs who serve on them to unnecessary antitrust liability.
In September, the AOA, in conjunction with 49 state affiliates, submitted an Amicus Curiae or "friend of the court" brief to the Supreme Court expressing those views. The California Optometric Association in the meantime submitted a similar, separate brief to the high court.
The brief makes the argument that state regulatory boards do qualify as "state actors" and should therefore be protected from federal antitrust laws and oversight by the Federal Trade Commission.
According to the brief, subjecting state licensing boards to this type of scrutiny would create a chilling effect where qualified ODs, for example, might not want to participate. "Doctors are the best qualified and necessary individuals to establish the minimum standards to protect the public health and welfare," the brief stated.
As with dentistry, state boards regulate optometry in all 50 states, with the requirement that ODs participate in these boards. For more than 30 years, antitrust liability has never been an issue for members of these boards, according to the AOA's brief.
If the high court upholds the appeals court's ruling, the decision is narrow enough that it's unlikely to reach beyond the North Carolina Dental Board. However, if it expands the decision to look at boards regulating nonlicensed professionals, it could have an impact on state optometry boards.
Medicare’s latest proposed rule builds on efforts to rein back Medicare Advantage plans with the AOA contributing comments that reiterate the need to eliminate plans’ barriers to care and promote transparency.
Ensuring our nation’s veterans have access to the full range of eye care they need, when and where they need it, has long been a mission for optometry’s advocates. Now, a pair of Veterans Health Administration directives affecting optometry could have far-reaching consequences beyond the nation’s largest integrated health care network.
In a recent one-on-one conversation with Federal Trade Commission staff, the AOA again urges the agency to reconsider a proposal requiring patients to sign forms attesting that they have received copies of their eyeglass prescriptions. For small-business optometric practices, the requirement would be burdensome from a paperwork perspective and unnecessary given that consumers are more empowered than ever, the AOA says—again.